Article
The role of PPP2R1A variants in gynecologic malignancies: a paradigm shift in immuno-oncology.
Journal of translational medicine - 30 Apr 2026
Chen Junying, Tan Yudi, Wei Yuying, Jin Yuxuan, Huang Jingwen
Abstract excerpt
BACKGROUND: Protein Phosphatase 2 A (PP2A), a key tumor suppressor, is frequently inactivated in cancer through mutations in its scaffold-encoding gene, PPP2R1A. This is particularly common in aggressive gynecologic malignancies, specifically uterine serous carcinoma (USC) and ovarian clear cell carcinoma (OCCC). A compelling paradox has emerged: while these mutations are potent oncogenic drivers, they are also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
